LIF · Life360, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-16 | Hulls Chris |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.46 to $56.13, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 134,496 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
14,345 |
| 2026-07-16 | Hulls Chris |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
27,000 |
| 2026-07-16 | Hulls Chris |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 134,496 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
27,000 |
| 2026-07-13 | Prober Charles J. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
7,930 |
| 2026-07-13 | Prober Charles J. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 4,455 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
7,930 |
| 2026-07-13 | Prober Charles J. |
Director, Chief Executive Officer |
Convert↑
Filing footnotes — Common stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 4,455 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
7,930 |
| 2026-07-01 | COGHLAN JOHN PHILIP |
Director |
Sell↓
Filing footnotes — Common stock (Indirect)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.52 to $56.47, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. |
Common stock
(I)
|
3,798 |
| 2026-07-01 | COGHLAN JOHN PHILIP |
Director |
Sell↓
Filing footnotes — Common stock (Indirect)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $56.52 to $56.67, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. |
Common stock
(I)
|
202 |
| 2026-06-29 | Morin Brit |
Director |
Sell↓
Filing footnotes — Common stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 4,636 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
4,655 |
| 2026-06-18 | Hulls Chris |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
27,000 |
| 2026-06-18 | Hulls Chris |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 134,496 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
27,000 |
| 2026-06-18 | Hulls Chris |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $46.92 to $47.39, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 134,496 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
16,042 |
| 2026-06-15 | Prober Charles J. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
7,930 |
| 2026-06-15 | Prober Charles J. |
Director, Chief Executive Officer |
Convert↑
Filing footnotes — Common stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 4,455 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
7,930 |
| 2026-06-15 | Prober Charles J. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 4,455 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
7,930 |
| 2026-06-12 | Burke Russell John |
Chief Financial Officer |
Other↓
Filing footnotes — Common stock (Indirect)
The Reporting Person transferred 15,000 indirectly held shares to each of (i) Jeanette Calandra TTEE The Jacaranda Trust, (ii) Jeanette Calandra TTEE The Waratah Trust, and (iii) Jeanette Calandra TTEE The Dianella Trust (45,000 shares in the aggregate), which transfers were exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. The Reporting Person retains indirect beneficial ownership of all transferred shares. |
Common stock
(I)
|
45,000 |
| 2026-06-08 | Hulls Chris |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units ("RSUs"). Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 134,496 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
7,544 |
| 2026-06-08 | Burke Russell John |
Chief Financial Officer |
Tax↓
Filing footnotes — Common stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units ("RSUs"). Includes 106,291 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
6,087 |
| 2026-06-08 | Antonoff Lauren |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units ("RSUs"). Includes 120,044 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
21,130 |
| 2026-06-01 | COGHLAN JOHN PHILIP |
Director |
Sell↓
Filing footnotes — Common stock (Indirect)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $43.53 to $44.52, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. |
Common stock
(I)
|
3,796 |
| 2026-06-01 | COGHLAN JOHN PHILIP |
Director |
Sell↓
Filing footnotes — Common stock (Indirect)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.63 to $44.64, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. |
Common stock
(I)
|
204 |
| 2026-05-29 | Morin Brit |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date. Includes 5,345 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
4,636 |
| 2026-05-29 | ZUCKERBERG RANDI |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date. Includes 5,134 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
4,455 |
| 2026-05-29 | Goines Mark |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date. Includes 6,102 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
5,322 |
| 2026-05-29 | COGHLAN JOHN PHILIP |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date. Includes 5,676 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
4,840 |
| 2026-05-29 | Haro Alex |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date. Includes 5,134 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
4,455 |
| 2026-05-29 | Synge James |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date. Includes 5,303 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. |
Common stock
|
4,600 |
| 2026-05-29 | Prober Charles J. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common stock (Direct)
Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date. Includes 5,134 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
4,455 |
| 2026-05-29 | Wiadrowski David |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date. Includes 5,554 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Includes common stock and the number of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. |
Common Stock
|
4,816 |
| 2026-05-28 | Hulls Chris |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 149,318 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
27,000 |
| 2026-05-28 | Hulls Chris |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
27,000 |
| 2026-05-28 | Hulls Chris |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $40.17 to $40.87, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 149,318 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
16,379 |
| 2026-05-13 | Prober Charles J. |
Director, Chief Executive Officer |
Convert↑
Filing footnotes — Common stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
7,930 |
| 2026-05-13 | Prober Charles J. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
7,930 |
| 2026-05-13 | Prober Charles J. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
7,930 |
| 2026-05-01 | COGHLAN JOHN PHILIP |
Director |
Sell↓
Filing footnotes — Common stock (Indirect)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $43.59 to $44.56, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. |
Common stock
(I)
|
3,736 |
| 2026-05-01 | COGHLAN JOHN PHILIP |
Director |
Sell↓
Filing footnotes — Common stock (Indirect)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.59 to $44.70, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. |
Common stock
(I)
|
264 |
| 2026-04-16 | Burke Russell John |
Chief Financial Officer |
Tax↓
Filing footnotes — Common stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Includes 118,188 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
2,193 |
| 2026-04-16 | Antonoff Lauren |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units ("RSUs"). The sale was to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the Reporting Person. Includes 161,566 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
2,716 |
| 2026-04-16 | Hulls Chris |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
27,000 |
| 2026-04-16 | Hulls Chris |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $45.36 to $46.11, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 149,318 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
16,105 |
| 2026-04-16 | Hulls Chris |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 149,318 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
27,000 |
| 2026-04-16 | Hulls Chris |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Includes 149,318 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common Stock
|
6,945 |
| 2026-04-14 | Burke Russell John |
Chief Financial Officer |
Award↑
Filing footnotes — Common stock (Direct)
Represents the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/48th of the RSUs will vest monthly from January 1, 2026, subject to the Reporting Person's continuous service through each vesting date. Represents 124,254 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
43,416 |
| 2026-04-13 | Prober Charles J. |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
7,930 |
| 2026-04-13 | Prober Charles J. |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
7,930 |
| 2026-04-13 | Prober Charles J. |
Director, Chief Executive Officer |
Convert↑
Filing footnotes — Common stock (Direct)
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
7,930 |
| 2026-04-01 | COGHLAN JOHN PHILIP |
Director |
Sell↓
Filing footnotes — Common stock (Indirect)
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $41.13 to $41.53, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. The Reporting Person transferred 35,366 directly held shares to the John Coghlan Living Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). |
Common stock
(I)
|
4,000 |
| 2026-03-26 | Haro Alex |
Director |
Convert↑
Filing footnotes — Common stock (Direct)
Includes 679 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
Common stock
|
15,972 |
| 2026-03-26 | Haro Alex |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The stock option is fully vested and exercisable. |
Stock Option (right to buy)
|
125,391 |